Tumor-based gene expression biomarkers to predict survival following curative intent resection for stage I lung adenocarcinoma.
Alisson ClemenceauNathalie GaudreaultCyndi HenryPaula A UgaldeCatherine LabbéMichel LaviolettePhilippe JoubertYohan BossePublished in: PloS one (2018)
Adenocarcinoma-specific mRNA expression levels of EZH2 and RRM1 are associated with poor post-surgical survival in the first set of patients, but not replicated in a clinically and pathologically matched independent validation set. This study highlights challenges associated with clinical translation of prognostic biomarkers.